Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Aug 1;89(15):7203-7.
doi: 10.1073/pnas.89.15.7203.

Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat

Affiliations
Comparative Study

Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat

L Negri et al. Proc Natl Acad Sci U S A. .

Abstract

Three naturally occurring dermorphin-like peptides from the skin of the frog Phyllomedusa bicolor, the related carboxyl-terminal amides, and some substituted analogs were synthesized, their binding profiles to opioid receptors were determined, and their biological activities were studied in isolated organ preparations and intact animals. The opioid binding profile revealed a very high selectivity of these peptides for mu sites and suggested the existence of two receptor subtypes, of high and low affinity. The peptides tested acted as potent mu opioid agonists on isolated organ preparations. They were several times more active in inhibiting electrically evoked contractions in guinea pig ileum than in mouse vas deferens. When injected into the lateral brain ventricle or peritoneum of rats, the high-affinity-site-preferring ligand, [Lys7-NH2]dermorphin, behaved as a potent analgesic agent. By contrast, the low-affinity-site-preferring ligand, [Trp4,Asn7-NH2]dermorphin, produced a weak antinociception but an intense catalepsy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1980 Nov;70(3):481-90 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4836-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5188-92 - PubMed
    1. Mol Pharmacol. 1989 Aug;36(2):265-72 - PubMed
    1. Mol Pharmacol. 1987 Jun;31(6):603-9 - PubMed

Publication types

MeSH terms